Synthesis and physicochemical characterization of the impurities of pemetrexed disodium, an anticancer drug

Molecules

Volumn 20, Issue 6, 2015, Pages 10004-10031

  Michalak, Olga ^a   Gruza, Mariusz M ^a   Witkowska, Anna ^a   Bujak, Iwona ^a   Cmoch, Piotr ^a,b  

^a INDUSTRIAL CHEMISTRY RESEARCH INSTITUTE   (Poland)

^b INSTITUTE OF ORGANIC CHEMISTRY   (Poland)

Author keywords

Diastereoisomers; Impurities; NMR; Pemetrexed

Indexed keywords

ANTINEOPLASTIC AGENT; DIPEPTIDE; ENZYME INHIBITOR; FORMAMIDE DERIVATIVE; PEMETREXED;

CHEMISTRY; HUMAN; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; QUALITY CONTROL; STEREOISOMERISM; SYNTHESIS;

ANTINEOPLASTIC AGENTS; DIPEPTIDES; ENZYME INHIBITORS; FORMAMIDES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; PEMETREXED; QUALITY CONTROL; STEREOISOMERISM;

EID: 84938258227     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules200610004     Document Type: Article

References (26)

1. Adjei, A.A. Pemetrexed (ALIMTA), A Novel Multitargeted Antineoplastic Agent. Clin. Cancer Res. 2004, 10, 4276s-4280s.
2. Walling, J. From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates. Investig. New Drugs 2006, 24, 37-77.
3. Hanauske, A.R.; Chen, V.; Paoletti, P.; Niyikiza, C. Pemetrexed Disodium: A Novel Antifolate Clinically Active against Multiple Solid Tumors. Oncologist 2001, 6, 363-373.
4. McGuire, J.J. Anticancer Antifolates: Current Status and Future Directions. Curr. Pharm. Des. 2003, 9, 2593-2613.
5. Taylor, E.C.; Kuhnt, D.; Shih, C.; Rinzel, S.M.; Grindey, G.B.; Barredo, J.; Jannatipour, M.; Moran, R.G. A dideazatetrahydrofolate analog lacking a chiral center at C-6: N-[4-[2-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-5yl)ethyl[benzoyl]-L-glutamic acid is an inhibitor of thymidylate synthase. J. Med. Chem. 1992, 35, 4450-4454.
6. Guidance for Industry on Abbreviated New Drug Applications: Impurities in Drug Substances; Availability. Fed. Regist. 2009, 74, 34359-34360.
7. The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline: Impurities in New Drug Substances Q3A (R2); IGH: Geneva, Switzerland, 2006.
8. Council of Europe. Pemetrexed disodium heptahydrate. In European Pharmacopoeia; EDQM, Council of Europe: Strasbourg, France, 2013; Volume 8, p. 2637.
9. International Conference on Harmonisation; revised guidance on Q3A impurities in new drug substances; availability. Notice. Fed. Regist. 2003, 68, 6924-6925.
10. Barnett, C.J.; Wilson, T.M.; Kobierski, M.E. A Practical Synthesis of Multitargeted Antifolate LY231514. Org. Process Res. Dev. 1999, 3, 184-188.
11. A manuscript describing the preparation of amorphic and hemipentahydrate pemetrexed disodium is under preparation.
12. Kjell, D.P.; Hallberg, D.W.; Kalbfleisch, J.M.; McCurry, C.K.; Semo, M.J.; Sheldon, E.M.; Spitler, J.T.; Wang, M. Determination of the Source of the N-Methyl Impurity in the Synthesis of Pemetrexed Disodium Heptahydrate. Org. Process Res. Dev. 2005, 9, 738-742.
13. Kadaboina, R.; Nariyam, S.M.; Murki, V.; Manda, A.; Vinjamuri, R.R.; Gunda, N. Processes for Preparing Pemetrexed. Patent WO2011019986, 13 October 2010.
14. Warner, A.; Piraner, I.; Weimer, H.; White, K. Development of a purity control strategy for pemetrexed disodium and validation of associated analytical methodology. J. Pharm. Biomed. Anal. 2015, 105, 46-54.
15. Abu-Shanab, F.A.; Redhouse, A.D.; Thompson, J.R.; Wakefield, B.J. Synthesis of 2,3,5,6-Tetrasubstituted Pyridines from Enamines Derived from N,N-Dimethylformamide Dimethyl Acetal. Synthesis 1995, 5, 557-560.
16. Nefkens, G.H.L.; Nivard, R.J.F. A new method for the synthesis of α-esters of N-acylglutamic acids. Recl. Trav. Chim. Pays Bas 1964, 83, 199-207.
17. Klieger, E.; Gibian, H. Über Peptidsynthesen, X. Vereinfachte Darstellung und Reaktionen von Carbobenzoxy-L-glutaminsäure-α-halbestern. Justus Liebigs Ann. Chem. 1962, 655, 195-210.
18. Garrett, C.E.; Jiang, X.; Prasad, K.; Repiè, O. New observations on peptide bond formation using CDMT. Tetrahedron Lett. 2002, 43, 4161-4165.
19. Sewald, N. Efficient, Racemization-Free Peptide Coupling of N-Alkyl Amino Acids by Using Amino Acid Chlorides Generated In Situ-Total Syntheses of the Cyclopeptides Cyclosporin O and Omphalotin A. Angew. Chem. Int. Ed. 2002, 41, 4661-4663.
20. Bodanszky M.; Klausner Y.S.; Ondetti M.A. Peptide Synthesis, 2nd ed.; Wiley-Interscience: New York, NY, USA, 1976.
21. Hanby, W.E.; Waley, S.G.; Watson, J. 632. Synthetic polypeptides. Part II. Polyglutamic acid. J. Chem. Soc. 1950, 3239-3249.
22. Taylor, E.C.; Liu, B. A New and Efficient Synthesis of Pyrrolo[2,3-d]pyrimidine Anticancer Agents: Alimta (LY231514, MTA), Homo-Alimta, TNP-351, and Some Aryl 5-Substituted Pyrrolo[2,3-d]pyrimidines. J. Org. Chem. 2003, 68, 9938-9947.
23. Hu, D.X.; Grice, P.; Ley, S.V. Rotamers or Diastereomers? An Overlooked NMR Solution. J. Org. Chem. 2012, 77, 5198-5202.
24. Pirrung, M.C. Appendix 3: Recipes for TLC Stains. In The Synthetic Organic Chemist's Companion; John Wiley & Sons, Inc.: Hoboken, NJ, US, 2007; pp. 171-172.
25. Gibian, H.; Schröder, E. Über Peptidsynthesen, III. Synthesen von Arginin-haltigen Peptiden. Justus Liebigs Ann. Chem. 1961, 642, 145-162.
26. Feng, X.; Edstrom, E.D. A synthetic approach to diaryl ethers using the Robinson annulation. Tetrahedron Asymmetry 1999, 10, 99-105.